As such, we have detected the expression level of DIO3OS in tumor samples from ER-positive breast cancer patients receiving AI therapy, and have demonstrated its prognostic value in these patients, further confirming the clinical relevance of above-mentioned findings. The gene discussed is DIO3OS; the disease is neoplasm.